NWAM LLC’s Oyster Point Pharma, Inc. Common Stock OYST Stock Holding History

NWAM LLC’s Portfolio OYST Stock Details OYST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-10,000	Closed	-$116K	–	569
2022 Q1	$116K	Hold	10,000	–	–	0.01%	516
2021 Q4	$183K	Hold	10,000	–	–	0.01%	490
2021 Q3	$119K	Hold	10,000	–	–	0.01%	481
2021 Q2	$172K	Hold	10,000	–	–	0.02%	455
2021 Q1	$183K	Hold	10,000	–	–	0.02%	466
2020 Q4	$188K	Hold	10,000	–	–	0.02%	427
2020 Q3	$211K	Hold	10,000	–	–	0.03%	213
2020 Q2	$289K	Buy	+10,000	New	+$301K	0.04%	326

Other funds holding OYST

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

IFA

Invus Financial Advisors New York $89.2M AUM 10.79% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

KKRC

Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return

TAM

Telemark Asset Management Boston, Massachusetts $1.08B AUM 70.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CAC

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

NWAM LLC's OYST Position: Q2 2022 in Review

NWAM LLC sold out of Oyster Point Pharma, Inc. Common Stock (OYST) in Q2 2022, closing a stake of 10,000 shares — an estimated $116K sold.

NWAM LLC first reported a position in OYST in Q2 2020 and held it in 8 quarters. The position peaked at $289K in Q2 2020. 61 funds tracked by Wall St. Rank hold OYST as of Q2 2022.

NWAM LLC reported no remaining Oyster Point Pharma, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
NWAM LLC sold 10,000 Oyster Point Pharma, Inc. Common Stock shares in Q2 2022, an estimated $116K.
NWAM LLC first reported a position in Oyster Point Pharma, Inc. Common Stock in Q2 2020 and held it in 8 quarters.
NWAM LLC's Oyster Point Pharma, Inc. Common Stock position peaked at $289K in Q2 2020.
61 funds tracked by Wall St. Rank held Oyster Point Pharma, Inc. Common Stock as of Q2 2022.

Based on NWAM LLC's 13F filing for Q2 2022, filed 10 Aug 2022.